UK Companies House feature
CRESCENT PHARMA LIMITED
Cash
£3M
-58.5% vs 2020
Net assets
£23M
+5.7% vs 2020
Employees
55
-19.1% vs 2020
Profit before tax
£349K
-97.2% vs 2020
Profile
- Company number
- 04750933
- Status
- Active
- Incorporation
- 2003-05-01
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
4-year trend · vs UK Healthcare median
Accounts
4-year trend · latest 2021-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £105,278,067 | £96,475,385 | |
| Operating profit | — | — | £12,630,548 | £448,557 | |
| Profit before tax | — | — | £12,539,557 | £349,331 | |
| Net profit | — | — | £10,178,876 | £1,253,649 | |
| Cash | — | — | £7,202,318 | £2,991,505 | |
| Total assets less current liabilities | — | — | £22,057,861 | £23,258,108 | |
| Net assets | — | — | £21,938,106 | £23,191,755 | |
| Equity | £21,278,553 | £11,759,230 | £21,938,106 | £23,191,755 | |
| Average employees | — | — | 68 | 55 | |
| Wages | — | — | — | £2,121,305 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- Crescent Pharma OTC Limited · 100% held · England
Significant events
- “On 4 July 2025, the company completed the purchase of a warehouse for a total consideration of £26,000,000. The agreement to purchase was signed after the balance sheet date.”
- “On 24 January 2025, Crescent Pharma Australia Pty Ltd was incorporated in Australia with its registered office at Level 2, 115 Pitt Street, Sydney, New South Wales, 2000. This new entity is a wholly owned subsidiary of Crescent Pharma Limited. The entity has been established to hold marketing authorisations in Australia and is not currently undertaking any operational activities.”
- “The company has continued with significant investment in research and development to add to it's product range.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AL-DOORI, Mohammed Khalid | Director | 2003-05-01 | Nov 1965 | British |
| ALDOORI, Laith Khalid | Director | 2023-06-07 | Dec 1989 | British |
| ALDOORI, Samie Mohammed | Director | 2023-06-07 | Aug 1991 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARTLETT, Margaret Mary | Secretary | 2003-05-01 | 2004-03-26 |
| ACORN ACCOUNTING SOLUTIONS LTD | Corporate Secretary | 2004-03-26 | 2009-03-31 |
| BRIGHTON SECRETARY LTD | Corporate Nominee Secretary | 2003-05-01 | 2003-05-06 |
| AUCHI, Luma | Director | 2003-05-01 | 2010-02-12 |
| MALONE, Gerald | Director | 2003-05-01 | 2010-02-12 |
| BRIGHTON DIRECTOR LTD | Corporate Nominee Director | 2003-05-01 | 2003-05-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Crescent Pharmaceuticals Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-01-29 | Active |
| Mr Mohammed Khalid Aldoori | Individual | Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 97 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-10-07 | AA | accounts | accounts with accounts type full |
| 2025-07-07 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-01-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-12 | AA | accounts | accounts with accounts type full |
| 2024-06-26 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-04-16 | RESOLUTIONS | resolution | resolution |
| 2024-04-12 | MA | incorporation | memorandum articles |
| 2024-04-05 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-04-05 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-04-05 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-04-04 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-01-30 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-01-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-27 | AA | accounts | accounts with accounts type full |
| 2023-06-20 | AP01 | officers | appoint person director company with name date |
| 2023-06-20 | AP01 | officers | appoint person director company with name date |
| 2023-01-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-23 | AA | accounts | accounts with accounts type full |
| 2022-05-03 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
Credit score
Altman Z″ (private-firm) · reference 2021-12-31
2.37
GREY ZONE
Altman Z″
- Working capital / Total assets 0.280 × 6.56 = +1.84
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.006 × 6.72 = +0.04
- Book equity / Total liabilities 0.468 × 1.05 = +0.49
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory